Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA292312 ID: 292312

Blast traumatic brain injury induced cognitive deficits are attenuated by pre- or post-injury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
AccessionPRJNA292312; GEO: GSE71850
TypeUmbrella project
Publications (total 3)
  • Tweedie D et al., "Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.", J Neurosci Methods, 2016 Oct 15;272:4-18
More...
SubmissionRegistration date: 7-Aug-2015
Computational Biology Core, Laboratory of Genetics and Genomics, NIA-IRP, NIH
RelevanceSuperseries
Project Data:
Resource NameNumber
of Links
Publications
PubMed4
PMC4
Other datasets
GEO DataSets3
GEO Data Details
ParameterValue
Data volume, Spots796607
Data volume, Processed Mbytes24
Data volume, Supplementary Mbytes6
Blast traumatic brain injury induced cognitive deficits are attenuated by pre- or post-injury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4 encompasses the following 2 sub-projects:
Project TypeNumber of Projects
Transcriptome or Gene expression2
BioProject
accession
OrganismTitle
PRJNA292313Mus musculusBlast traumatic brain injury induced cognitive deficits are attenuated by pre- or post-injury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4 [Day 3 dataset] (Computational Biology Core,...)
PRJNA190677Mus musculusChanges in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury (Computational Biology Core,...)

Supplemental Content

Recent activity

  • Blast traumatic brain injury induced cognitive deficits are attenuated by pre- o...
    Blast traumatic brain injury induced cognitive deficits are attenuated by pre- or post-injury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4
    Blast traumatic brain injury induced cognitive deficits are attenuated by pre- or post-injury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center